Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 38 results.
User Information
Export Records
  1. 1.   Development of patient reported outcome measures assessing tumor pain intensity and tumor pain interference for individuals with neurofibromatosis type 1 and plexiform neurofibromas: qualitative findings
  2. Al Ghriwati, Nour; Struemph, Kari; Martin, Staci; Little, Paige; Baker, Melissa; Levine, Jason; MacKenzie, Cynthia; Tonsgard, James; Schorry, Elizabeth K; Walsh, Karin S; Wolters, Pamela L
  3. Journal of Patient-Reported Outcomes. 2025, Apr 30; 9(1): 46.
  1. 2.   Allosteric modulation of NF1 GAP: Differential distributions of catalytically competent populations in loss-of-function and gain-of-function mutants
  2. Xu,Liang; Jang,Hyunbum; Nussinov,Ruth
  3. Protein Science : a publication of the Protein Society. 2025, Feb; 34(2): e70042.
  1. 3.   A Mixed Methods Study of Medication Adherence in Adults with Neurofibromatosis Type 1 (NF1) on a Clinical Trial of Selumetinib
  2. Curlee, Millicent S; Toledo-Tamula, Mary Anne; Baker, Melissa; Wikstrom, Daniel; Harrison, Cynthia; Rhodes, Amanda; Fagan, Margaret; Tibery,Cecilia; Wolters, Pamela L; Widemann, Brigitte C; Gross, Andrea M; Martin, Staci
  3. Cancers. 2025, Jan 17; 17(2):
  1. 4.   Recommendations for assessing appearance concerns related to plexiform and cutaneous neurofibromas in neurofibromatosis 1 clinical trials
  2. Merker, Vanessa L; Thompson, Heather L; Wolters, Pamela L; Buono, Frank D; Hingtgen, Cynthia M; Rosser, Tena; Barton, Belinda; Barnett, Carolina; Smith, Taylor; Haberkamp, Diana; McManus, Miranda L; Baldwin,Andrea; Moss, Irene P; Röhl, Claas; Martin, Staci
  3. Clinical Trials (London, England). 2023, Dec 23; 17407745231205577.
  1. 5.   Perspectives of adults with neurofibromatosis regarding the design of psychosocial trials: Results from an anonymous online survey
  2. Wolters, Pamela L; Al Ghriwati,Nour; Baker, Melissa; Martin, Staci; Berg, Dale; Erickson, Gregg; Franklin, Barbara; Merker, Vanessa L; Oberlander, Beverly; Reeve, Stephanie; Rohl, Claas; Rosser, Tena; Vranceanu, Ana-Maria
  3. Clinical Trials (London, England). 2023, Nov 14;
  1. 6.   Development and pilot validation of a novel disfigurement severity scale for plexiform neurofibromas in children with neurofibromatosis type 1
  2. John, Liny; Singh, Gurbani; Dombi, Eva; Wolters, Pamela L; Martin, Staci; Baldwin, Andrea; Steinberg, Seth M; Bernstein, Jessica; Whitcomb, Patricia; Pichard, Dominique C; Dufek, Anne; Gillespie, Andy; Heisey, Kara; Bornhorst, Miriam; Fisher, Michael J; Weiss, Brian D; Kim, AeRang; Widemann, Brigitte C; Gross, Andrea M
  3. Clinical Trials (London, England). 2023, Oct 25; 17407745231206402.
  1. 7.   Long-Term Safety and Efficacy of Selumetinib in Children with Neurofibromatosis Type 1 on a Phase 1/2 Trial for Inoperable Plexiform Neurofibromas
  2. Gross, Andrea M; Dombi, Eva; Wolters, Pamela L; Baldwin, Andrea; Dufek, Anne; Herrera, Kailey; Martin, Staci; Derdak, Joanne; Heisey,Kara; Whitcomb, Patricia M; Steinberg, Seth M; Venzon, David J; Fisher, Michael J; Kim, Ae Rang; Bornhorst, Miriam; Weiss, Brian D; Blakeley, Jaishri O; Smith, Malcolm A; Widemann, Brigitte C
  3. Neuro-Oncology. 2023, Apr 28;
  1. 8.   Destabilizing NF1 variants act in a dominant negative manner through neurofibromin dimerization
  2. Young, Lucy C; Goldstein de Salazar, Ruby; Han, Sae-Won; Huang, Zi Yi Stephanie; Merk,Alan; Drew,Matt; Darling, Joseph; Wall,Vanessa; Grisshammer, Reinhard; Cheng, Alice; Allison, Madeline R; Sale, Matthew J; Nissley,Dwight; Esposito,Dom; Ognjenovic, Jana; McCormick, Frank
  3. Proceedings of the National Academy of Sciences of the United States of America. 2023, Jan 31; 120(5): e2208960120.
  1. 9.   Demographic and Disease-Related Predictors of Socioemotional Development in Children with Neurofibromatosis Type 1 and Plexiform Neurofibromas: An Exploratory Study
  2. Hou, Yang; Wu, Xian; Liu, Dan; Martin, Staci; Tamula,Mary Anne; Allen, Taryn; Baldwin,Andrea; Gillespie, Andy; Goodwin, Anne; Widemann, Brigitte C; Wolters, Pamela L
  3. Cancers. 2022, Dec 01; 14(23):
  1. 10.   Single-cell sequencing reveals activation of core transcription factors in PRC2-deficient malignant peripheral nerve sheath tumor
  2. Zhang, Xiyuan; Lou, Hannah E; Gopalan, Vishaka; Liu, Zhihui; Jafarah, Hilda M; Lei, Haiyan; Jones, Paige; Sayers, Carly M; Yohe, Marielle E; Chittiboina, Prashant; Widemann, Brigitte C; Thiele, Carol J; Kelly,Michael; Hannenhalli, Sridhar; Shern, Jack F
  3. Cell Reports. 2022, Sep 20; 40(12): 111363.
  1. 11.   Verbal learning and memory in youth with neurofibromatosis type 1 and plexiform neurofibromas: Relationships with disease severity
  2. Loucas, Caitlyn; Wolters, Pamela; Tamula,Mary Anne; Rhodes, Amanda; Baldwin,Andrea; Goodwin, Anne; Widemann, Brigitte; Martin, Staci
  3. European Journal of Paediatric Neurology : EJPN : official journal of the European Paediatric Neurology Society. 2022, Mar 13; 38: 7-12.
  1. 12.   The seventh international RASopathies symposium: Pathways to a cure-expanding knowledge, enhancing research, and therapeutic discovery
  2. Kontaridis, Maria I; Roberts, Amy E; Schill, Lisa; Schoyer, Lisa; Stronach, Beth; Andelfinger, Gregor; Aoki, Yoko; Axelrad, Marni E; Bakker, Annette; Bennett, Anton M; Broniscer, Alberto; Castel, Pau; Chang, Caitlin A; Cyganek, Lukas; Das, Tirtha K; den Hertog, Jeroen; Galperin, Emilia; Garg, Shruti; Gelb, Bruce D; Gordon, Kristiana; Green, Tamar; Gripp, Karen W; Itkin, Maxim; Kiuru, Maija; Korf, Bruce R; Livingstone, Jeff R; López-Juárez, Alejandro; Magoulas, Pilar L; Mansour, Sahar; Milner, Theresa; Parker, Elisabeth; Pierpont, Elizabeth I; Plouffe, Kevin; Rauen, Katherine A; Shankar, Suma P; Smith, Shane B; Stevenson, David A; Tartaglia, Marco; Van, Richard; Wagner,Morgan; Ware, Stephanie M; Zenker, Martin
  3. American Journal of Medical Genetics. Part A. 2022, Mar 09;
  1. 13.   Acceptance and commitment therapy for adolescents and adults with neurofibromatosis type 1, plexiform neurofibromas, and chronic pain: Results of a randomized controlled trial
  2. Martin, Staci; Allen,Taryn; Toledo-Tamula, Mary Anne; Struemph,Kari; Reda, Stephanie; Wolters, Pamela L.; Baldwin,Andrea; Quinn, Mary; Widemann, Brigitte C.
  3. Journal of Contextual Behavioral Science. 2021, Oct; 22: 93-101.
  1. 14.   Impact of the coronavirus pandemic on mental health and health care in adults with neurofibromatosis: Patient perspectives from an online survey
  2. Wolters, Pamela L.; Reda, Stephanie; Martin, Staci; Al Ghriwati, Nour; Baker, Melissa; Berg, Dale; Erickson, Gregg; Franklin, Barbara; Merker, Vanessa L.; Oberlander, Beverly; Reeve, Stephanie; Rohl, Claas; Rosser, Tena; Tamula,Mary Anne; Vranceanu, Ana-Maria
  3. American journal of medical genetics. Part A. 2021, Sep 18;
  1. 15.   Genome-wide association study of café-au-lait macule number in neurofibromatosis type 1
  2. Sung, Heejong; Hyland, Paula L; Pemov, Alexander; Sabourin, Jeremy A; Baldwin, Andrea M; Bass,Sara; Teshome,Kedest; Luo,Wen; Widemann, Brigitte C; Stewart, Douglas R; Wilson, Alexander F
  3. Molecular genetics & genomic medicine. 2020, Aug 31; e1400.
  1. 16.   Structural Insights into the SPRED1-Neurofibromin-KRAS Complex and Disruption of SPRED1-Neurofibromin Interaction by Oncogenic EGFR
  2. Yan,Wupeng; Markegard, Evan; Dharmaiah, Srisathiyanarayanan; Urisman, Anatoly; Drew, Matthew; Esposito,Dom; Scheffzek, Klaus; Nissley,Dwight; McCormick, Frank; Simanshu,Dhirendra
  3. Cell reports. 2020, Jul 21; 32(3): 107909.
  1. 17.   Low mutation burden and frequent loss of CDKN2A/B and SMARCA2, but not PRC2, define pre-malignant neurofibromatosis type 1-associated atypical neurofibromas
  2. Pemov, Alexander; Hansen, Nancy F; Sindiri, Sivasish; Patidar, Rajesh; Higham, Christine S; Dombi, Eva; Miettinen, Markku M; Fetsch, Patricia; Brems, Hilde; Chandrasekharappa, Settara; Jones, Kristine; Zhu, Bin; Wei, Jun S; Mullikin, James C; Wallace, Margaret R; Khan, Javed; Legius, Eric; Widemann, Brigitte C; Stewart, Douglas R
  3. Neuro-oncology. 2019, AUG; 21(8): 981-992.
  1. 18.   Proceedings of the fifth international RASopathies symposium: When development and cancer intersect
  2. Rauen, Katherine A.; Schoyer, Lisa; Schill, Lisa; Stronach, Beth; Albeck, John; Andresen, Brage S.; Cave, Helene; Ellis, Michelle; Fruchtman, Steven M.; Gelb, Bruce D.; Gibson, Christopher C.; Gripp, Karen; Hefner, Erin; Huang, William Y. C.; Itkin, Maxim; Kerr, Bronwyn; Linardic, Corinne M.; McMahon, Martin; Oberlander, Beverly; Perlstein, Ethan; Ratner, Nancy; Rogers, Leslie; Schenck, Annette; Shankar, Suma; Shvartsman, Stanislav; Stevenson, David A.; Stites, Edward C.; Stork, Philip J. S.; Sun, Cheng; Therrien, Marc; Ullian, Erik M.; Widemann, Brigitte C.; Yeh, Erika; Zampino, Giuseppe; Zenker, Martin; Timmer, William; McCormick, Frank
  3. AMERICAN JOURNAL OF MEDICAL GENETICS PART A. 2018, Dec; 176(12): 2924-2929.
  1. 19.   The Relationship between Heart Rate Variability, Psychological Flexibility, and Pain in Neurofibromatosis Type 1
  2. Allen, Taryn; Struemph, Kari L; Tamula, Mary Anne; Wolters, Pamela L; Baldwin, Andrea; Widemann, Brigitte; Martin, Staci
  3. Pain practice : the official journal of World Institute of Pain. 2018, Nov; 18(8): 969-978.
  1. 20.   An Internet support group for parents of children with neurofibromatosis type 1: a qualitative analysis
  2. Martin, Staci; Struemph, Kari L; Poblete, Alyssa; Tamula, Mary Anne; Lockridge, Robin; Roderick, Marie Claire; Wolters, Pamela
  3. Journal of community genetics. 2018, Jul; 9(3): 327-334.
  1. 21.   RAS Proteins and Their Regulators in Human Disease
  2. Simanshu, Dhirendra; Nissley, Dwight; McCormick, Frank
  3. Cell. 2017, Jun 29; 170(1): 17-33.
  1. 22.   Feasibility and Preliminary Efficacy of an Internet Support Group for Parents of a Child with Neurofibromatosis Type 1: a Pilot Study
  2. Martin, S.; Roderick, M. C.; Lockridge, R.; Toledo-Tamula, M. A.; Baldwin, A.; Knight, P.; Wolters, P.
  3. Journal of Genetic Counseling. 2017, Jun; 26(3): 576-585.
  1. 23.   miRNA-7 Attenuation in Schwannoma Tumors Stimulates Growth by Upregulating Three Oncogenic Signaling Pathways
  2. Saydam, O.; Senol, O.; Wurdinger, T.; Mizrak, A.; Ozdener, G. B.; Stemmer-Rachamimov, A. O.; Yi, M.; Stephens, R. M.; Krichevsky, A. M.; Saydam, N.; Brenner, G. J.; Breakefield, X. O.
  3. Cancer Research. 2011, Feb; 71(3): 852-861.
  1. 24.   Back to the Future: Proceedings From the 2010 NF Conference
  2. Huson, S. M.; Acosta, M. T.; Belzberg, A. J.; Bernards, A.; Chernoff, J.; Cichowski, K.; Evans, D. G.; Ferner, R. E.; Giovannini, M.; Korf, B. R.; Listernick, R.; North, K. N.; Packer, R. J.; Parada, L. F.; Peltonen, J.; Ramesh, V.; Reilly, K. M.; Risner, J. W.; Schorry, E. K.; Upadhyaya, M.; Viskochil, D. H.; Zhu, Y. A.; Hunter-Schaedle, K.; Giancotti, F. G.
  3. American Journal of Medical Genetics Part A. 2011, Feb; 155A(2): 307-321.
  1. 25.   Evidence of perturbations of cell cycle and DNA repair pathways as a consequence of human and murine NF1-haploinsufficiency
  2. Pemov, A.; Park, C.; Reilly, K. M.; Stewart, D. R.
  3. Bmc Genomics. 2010, Mar; 11: 16.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel